Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury

Journal of Molecular Medicine

Volumn 84, Issue 10, 2006, Pages 842-851

  Dorner A ^a   Grunert, H P ^a   Lindig, V ^a   Chandrasekharan, K ^a   Fechner, H ^a   Knowlton, K U ^b   Isik, A ^a   Pauschinger, M ^a   Zeichhardt, H ^a   Schultheiss, H P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

Coxsackie adenovirus receptor; Coxsackievirus B3; Myocarditis

Indexed keywords

ANTIVIRUS AGENT; BETA GALACTOSIDASE; BUFFER; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR 4 7; PLASMID DNA; PLASMID VECTOR; RECOMBINANT RECEPTOR; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CELL MEMBRANE; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DISEASE EXACERBATION; DRUG EFFECT; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; HEART INJURY; HISTOLOGY; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO CULTURE; IN VIVO STUDY; INOCULATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; SOLUBILITY; VIRUS INHIBITION; VIRUS LOAD; VIRUS MYOCARDITIS; VIRUS TITRATION;

ANIMALS; ANTIVIRAL AGENTS; CELL SURVIVAL; COXSACKIEVIRUS INFECTIONS; CREATINE KINASE; ENTEROVIRUS B, HUMAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELA CELLS; HUMANS; IMMUNE SERA; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; RANDOM ALLOCATION; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; SERUM AMYLOID A PROTEIN; SOLUBILITY;

EID: 33749185432     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-006-0076-y     Document Type: Article

References (39)

1. Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R, Schultheiss HP (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889-895
2. Gauntt C, Huber S (2003) Coxsackievirus experimental heart diseases. Front Biosci 8:e23-e35
3. Noutsias M, Pauschinger M, Poller WC, Schultheiss HP, Kuhl U (2003) Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit 3:127-135
4. Dörner A, Kallwellis-Opara A, Pauschinger M, Kühl U, Schultheiss HP (2005) Cardiac autoantibodies in viral myocarditis. In: Narula J, Young JB (eds) Heart failure clinics. Myocarditis. Saunders, Philadelphia, pp 333-343
5. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323
6. He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, Baker TS, Kuhn RJ, Anderson CW, Freimuth P, Rossmann MG (2001) Interaction of coxsackievirus B3 with the full length coxsackie-virus-adenovirus receptor. Nat Struct Biol 8:874-878
7. Bergelson JM, Mohanty JG, Crowell RL, St. John NF, Lublin DM, Finberg RW (1995) Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 69:1903-1906
8. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD (1995) Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 69:3873-3877
9. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM (2001) The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 98:15191-15196
10. Noutsias M, Fechner H, de Jonge H, Wang X, Dekkers D, Houtsmuller AB, Pauschinger M, Bergelson J, Warraich R, Yacoub M, Hetzer R, Lamers J, Schultheiss HP, Poller W (2001) Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 104:275-280
11. Honda T, Saitoh H, Masuko M, Katagiri-Abe T, Tominaga K, Kozakai I, Kobayashi K, Kumanishi T, Watanabe YG, Odani S, Kuwano R (2000) The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res Mol Brain Res 77:19-28
12. Coyne CB, Bergelson JM (2006) Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124:119-131
13. Asher DR, Cerny AM, Weiler SR, Horner JW, Keeler ML, Neptune MA, Jones SN, Bronson RT, Depinho RA, Finberg RW (2005) Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis 42(2):77-85
14. Dorner AA, Wegmann F, Butz S, Wolburg-Buchholz K, Wolburg H, Mack A, Nasdala I, August B, Westermann J, Rathjen FG, Vestweber D (2005) Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development. J Cell Sci 118 (15):3509-3521
15. Tomko RP, Johansson CB, Totrov M, Abagyan R, Frisen J, Philipson L (2000) Expression of the adenovirus receptor and its interaction with the fiber knob. Exp Cell Res 255:47-55
16. Philipson L, Pettersson RF (2004) The coxsackie-adenovirus receptor - a new receptor in the immunoglobulin family involved in cell adhesion. Curr Top Microbiol Immunol 273:87-111
17. Carson SD, Chapman NM (2001) Coxsackievirus and adenovirus receptor (CAR) binds immunoglobulins. Biochemistry 40:14324-14329
18. Zen K, Liu Y, McCall IC, Wu T, Lee W, Babbin BA, Nusrat A, Parkos CA (2005) Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils. Mol Biol Cell 16:2694-2703
19. Chen JW, Ghosh R, Finberg RW, Bergelson JM (2003) Structure and chromosomal localization of the murine coxsackievirus and adenovirus receptor gene. DNA Cell Biol 22:253-259
20. Dörner A, Xiong D, Couch K, Yajima T, Knowlton KU (2004) Alternatively spliced soluble coxsackie-adenovirus receptors inhibit coxsackievirus infection. J Biol Chem 279:18497-18503
21. Thoelen I, Magnusson C, Tagerud S, Polacek C, Lindberg M, Van RM (2001) Identification of alternative splice products encoded by the human coxsackie-adenovirus receptor gene. Biochem Biophys Res Commun 287:216-222
22. Carson SD (2004) Coxsackievirus and adenovirus receptor (CAR) is modified and shed in membrane vesicles. Biochemistry 43:8136-8142
23. Bernal RM, Sharma S, Gardner BK, Douglas JT, Bergelson JM, Dubinett SM, Batra RK (2002) Soluble coxsackievirus adenovirus receptor is a putative inhibitor of adenoviral gene transfer in the tumor milieu. Clin Cancer Res 8:1915-1923
24. Walters RW, Freimuth P, Moninger TO, Ganske I, Zabner J, Welsh MJ (2001) Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 110(6):789-799
25. Yanagawa B, Spiller OB, Proctor DG, Choy J, Luo H, Zhang HM, Suarez A, Yang D, McManus BM (2004) Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice. J Infect Dis 189:1431-1439
26. Wetz K, Willingmann P, Zeichhardt H, Habermehl KO (1986) Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion. Arch Virol 91:207-220
27. Yanagawa B, Spiller OB, Choy J, Luo H, Cheung P, Zhang HM, Goodfellow IG, Evans DJ, Suarez A, Yang D, McManus BM (2003) Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in mice. Lab Invest 83:75-85
28. Noutsias M, Pauschinger M, Schultheiss HP, Kuhl U (2002) Phenotypic characterization of infiltrates in dilated cardiomyopathy-diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Med Sci Monit 8:CR478-CR487
29. Lawson CM (2000) Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol Life Sci 57:552-560
30. Fechner H, Wang X, Wang H, Jansen A, Pauschinger M, Scherubl H, Bergelson JM, Schultheiss HP, Poller W (2000) Transcomplementation of vector replication versus coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells. Gene Ther 7:1954-1968
31. Carson SD, Hobbs JT, Tracy SM, Chapman NM (1999) Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density. J Virol 73:7077-7079
32. Takada H, Kishimoto C, Hiraoka Y (1995) Therapy with immunoglobulin suppresses myocarditis in a murine coxsackie-virus B3 model. Antiviral and anti-inflammatory effects. Circulation 92:1604-1611
33. Goodfellow IG, Evans DJ, Blom AM, Kerrigan D, Miners JS, Morgan BP, Spiller OB (2005) Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J Virol 79:12016-12024
34. Orthopoulos G, Triantafilou K, Triantafilou M (2004) Coxsackie B viruses use multiple receptors to infect human cardiac cells. J Med Virol 74:291-299
35. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 139:3630-3636
36. Schulze K, Becker BF, Schultheiss HP (1989) Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res 64:179-192
37. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419-1429
38. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T (2003) Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 9:1477-1483
39. Takai T (2002) Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2:580-592